SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019775
Filing Date
2023-05-09
Accepted
2023-05-09 16:36:47
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-20230331.htm   iXBRL 10-Q 2522752
2 EX-31.1 xene-ex31_1.htm EX-31 20250
3 EX-31.2 xene-ex31_2.htm EX-31 20220
4 EX-32.1 xene-ex32_1.htm EX-32 14619
5 EX-32.2 xene-ex32_2.htm EX-32 13904
  Complete submission text file 0000950170-23-019775.txt   7623836

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xene-20230331_pre.xml EX-101.PRE 251313
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xene-20230331_cal.xml EX-101.CAL 45194
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xene-20230331_lab.xml EX-101.LAB 358008
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xene-20230331_def.xml EX-101.DEF 125577
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xene-20230331.xsd EX-101.SCH 45949
50 EXTRACTED XBRL INSTANCE DOCUMENT xene-20230331_htm.xml XML 1332923
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 23902775
SIC: 2834 Pharmaceutical Preparations